USANA Health Sciences, Inc.USNANYSE
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank13
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P13
Within normal range
vs 3Y Ago
-1.9x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q1 2026 | -72.87% |
| Q3 2025 | -116.05% |
| Q2 2025 | -21.08% |
| Q1 2025 | 167.62% |
| Q4 2024 | -80.41% |
| Q3 2024 | 269.64% |
| Q2 2024 | -54.82% |
| Q1 2024 | -32.05% |
| Q4 2023 | 17.04% |
| Q3 2023 | 132.79% |
| Q3 2023 | -25.57% |
| Q2 2023 | -68.28% |
| Q4 2022 | 38.93% |
| Q4 2022 | 99.31% |
| Q3 2022 | -25.83% |
| Q2 2022 | -20.95% |
| Q4 2021 | -33.52% |
| Q4 2021 | -4.26% |
| Q3 2021 | 99.19% |
| Q2 2021 | -58.97% |
| Q4 2020 | -2.34% |
| Q3 2020 | 50.32% |
| Q2 2020 | 6.02% |
| Q1 2020 | -44.77% |
| Q4 2019 | 10.78% |
| Q3 2019 | 231.93% |
| Q2 2019 | 174.55% |
| Q1 2019 | -86.34% |
| Q4 2018 | -25.82% |
| Q3 2018 | 44.66% |
| Q2 2018 | 93.03% |
| Q1 2018 | -64.60% |
| Q4 2017 | 322.90% |
| Q3 2017 | -75.73% |
| Q3 2017 | 2725.46% |
| Q2 2017 | -96.56% |
| Q4 2016 | 63.76% |
| Q4 2016 | -2.15% |
| Q3 2016 | 156.15% |
| Q2 2016 | -63.54% |